Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Pulmonary Sarcoidosis
NCT00279708Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jan 2006
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary sarcoidosis comparing Atorvastatin with Placebo (2 arms). Primary endpoint: The Steroid Sparing Period at 1 year. Started Jan 2006; status: completed.
02
Drugs
atorvastatin
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT00279708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00279708.